Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2000
12/12/2000US6159955 Use of hyaluronic acid and a NSAID for the manufacture of a medicament for the treatment of mucosal diseases
12/12/2000US6159943 Use of ribose to prevent cramping and soreness in muscles
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159711 Amino acid sequences; antiinflammatory agents; treatment of asthma, allergic rhinitis or atopic dermatitis
12/12/2000US6159694 Antisense modulation of stat3 expression
12/12/2000US6159485 Cosmetics; skin disorders
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000US6159450 Use of Ginkgo biloba flavonoidic extract substantially devoid of terpenes for oral hygiene and composition containing such extract
12/12/2000CA2168247C Nitric oxide donor composition and method for treatment of anal disorders
12/12/2000CA2120506C Treatment of ocular inflammation by blockage of cell adhesion molecules
12/12/2000CA1341152C Receptor protein for human b cell stimulatory factor-2
12/11/2000CA2274419A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/10/2000CA2311039A1 Rapidly absorbed liquid compositions
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073481A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073302A1 Oxazaheterocycles as protease inhibitors
12/07/2000WO2000073296A2 3-heteroarylalkyl substituted gaba analogs
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073283A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000WO2000073282A1 Il-8 receptor antagonists
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073279A1 4-phenyl-pyrimidine derivatives
12/07/2000WO2000073278A2 5-phenyl-pyrimidine derivatives
12/07/2000WO2000073260A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000WO2000073253A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS
12/07/2000WO2000072884A1 A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
12/07/2000WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072867A2 Substantially oil-free cyclosporin compositions
12/07/2000WO2000072864A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000WO2000072861A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072838A1 New use of compounds as antibacterial agents
12/07/2000WO2000072832A2 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts
12/07/2000WO2000072822A1 Preparations for the application of anti-infective and/or anti-inflammatory agents
12/07/2000WO2000072815A1 Indole derivatives
12/07/2000WO2000072801A2 Alpha v integrin receptor antagonists
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
12/07/2000WO2000041514A3 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2694866A1 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
12/07/2000CA2414094A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000CA2376024A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375657A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000CA2375218A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000CA2375147A1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2374597A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2373937A1 Alpha v integrin receptor antagonists
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2372234A1 Oxazaheterocycles as protease inhibitors
12/07/2000CA2371247A1 Substantially oil-free cyclosporin compositions
12/07/2000CA2371089A1 3-heteroarylalkyl substituted gaba analogs
12/06/2000EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy
12/06/2000EP1056854A2 Protease-activated receptor 4 and uses thereof
12/06/2000EP1056842A2 Genetic vaccine vector engineering
12/06/2000EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
12/06/2000EP1056760A1 36 human secreted proteins
12/06/2000EP1056759A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
12/06/2000EP1056743A1 Benzamine derivatives
12/06/2000EP1056728A1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
12/06/2000EP1056719A2 Inhibitors of phospholipase enzymes
12/06/2000EP1056714A1 Phenylalanine derivatives as inhibitors of alpha4 integrins
12/06/2000EP1056710A1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
12/06/2000EP1056470A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
12/06/2000EP1056455A1 Epimorphian compound and its use
12/06/2000EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
12/06/2000EP1024701A4 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
12/06/2000CN1275979A Isoquinolines as urokinase inhibitors
12/06/2000CN1275910A Therapeutic agents
12/06/2000CN1275908A Preparation of directly mouldable tabletting auxiliary
12/05/2000US6156887 Compositions and methods for the treatment and diagnosis of immune disorders
12/05/2000US6156881 Inhibition of cell adhesion protein-carbohydrate interactions
12/05/2000US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders
12/05/2000US6156798 Cardiovascular disorders, nervous system disorders, antiarthritic disorders and enzyme inhibitors
12/05/2000US6156788 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000US6156750 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156571 Oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding steroid receptor coactivator-3; diagnosis and therapy of related disorders
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156516 Method for screening substance inhibiting activation of NF-κB
12/05/2000CA2188066C Thio-substituted phosphonate compounds
12/05/2000CA2136822C Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
11/2000
11/30/2000WO2000071718A1 Gene therapy of pulmonary disease
11/30/2000WO2000071717A1 Secreted alpha-helical protein - 32
11/30/2000WO2000071679A2 Human oxidoreductase proteins
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000WO2000071574A2 Antigenic neisserial peptides
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
1 ... 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 ... 1272